New Orleans – The Food and Drug Administration's approval of warnings on a drug label doesn't clear the manufacturer of claims that the warnings were inadequate, a judge ruled Tuesday in a decision affecting thousands of federal lawsuits against Merck over the painkiller Vioxx. 

"The FDA's current view on the question of immunity for prescription-drug manufacturers is entirely unpersuasive," U.S. District Judge Eldon E. Fallon wrote.

Fallon rejected Merck's attempt to throw out lawsuits brought in the cases of two people who began taking Vioxx after April 2002, when the FDA approved a label warning that the drug might increase the chance of heart attacks and other cardiovascular problems.

Lene Arnold, who had a heart attack in December 2003, and the family of Joe G. Gomez, who died of one in January 2003, claim that the warning was inadequate.

"Failure to warn" is a state claim, but where there is no parallel federal law, federal courts apply state laws in the jurisdiction where a suit is filed.

In a preamble to rules set in 2006, the FDA contends that its requirements set the limits for prescription-drug labels, pre-empting state claims that a company failed to warn users of a danger.

However, Fallon wrote, "Because there are no federal remedies for individuals harmed by prescription drugs, a finding of implied pre-emption in these cases would abolish state-law remedies and would, in effect, render legally impotent those who sustain injuries from defective prescription drugs."

Had Merck won, it could have challenged claims brought by thousands of other plaintiffs.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Merck to fund Vioxx settlement in August

Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month...

Best firm by far

Our case was handled with the utmost integrity and professionalism. If I could give them 10 stars, I would. This is the best legal firm I have ever dealt with by far.

—Pat